Viewing Study NCT04688658


Ignite Creation Date: 2025-12-25 @ 12:16 AM
Ignite Modification Date: 2026-03-16 @ 5:48 PM
Study NCT ID: NCT04688658
Status: TERMINATED
Last Update Posted: 2025-12-17
First Post: 2020-12-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
Sponsor: John Kirkwood
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-PD-1 monoclonal antibody (mAb) View